Bulk Manufacturer of Controlled Substances Application: Organix, Inc., 23376 [2014-09553]
Download as PDF
<![CDATA[
23376
Federal Register / Vol. 79, No. 81 / Monday, April 28, 2014 / Notices
interest, and with United States
obligations under international treaties,
conventions, or protocols in effect on
May 1, 1971. DEA has investigated
Mylan Pharmaceuticals, Inc., to ensure
that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the above named
company is granted registration as an
importer of the basic classes of
controlled substances listed.
Dated: April 21, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2014–09574 Filed 4–25–14; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Organix, Inc.
Notice of application with
opportunity for comment.
ACTION:
Registered bulk manufacturers of
the affected basic classes and applicants
therefore may file written comments or
objections to the issuance of the
proposed registration in accordance
with 21 CFR 1301.33(a) on or before
June 27, 2014.
ADDRESSES: Written comments should
be sent via regular or express mail to:
Drug Enforcement Administration,
Attention: DEA Federal Register
Representative/ODW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
DATES:
Controlled substance
Schedule
Gamma Hydroxybutyric Acid (2010) ...............................................
Lysergic acid diethylamide (7315) ..................................................
Heroin (9200) ..................................................................................
Morphine (9300) ..............................................................................
I ..............
I ..............
I ..............
II .............
The company plans to manufacture
reference standards for distribution to
its research and forensics customers.
Dated: April 21, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014–09553 Filed 4–25–14; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
tkelley on DSK3SPTVN1PROD with NOTICES
Manufacturer of Controlled
Substances; Notice of Registration;
American Radiolabeled Chemicals, Inc.
By Notice dated December 16, 2013,
and published in the Federal Register
on January 2, 2014, 79 FR 151,
American Radiolabeled Chemicals, Inc.,
101 Arc Drive, St. Louis, Missouri
63146, made application by written
correspondence to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
Methadone (9250), a basic class of
controlled substance listed in schedule
II.
The company plans to manufacture
small quantities of the listed controlled
VerDate Mar<15>2010
17:06 Apr 25, 2014
Jkt 232001
Narcotic/Nonnarcotic
nonnarcotic
nonnarcotic
narcotic
narcotic
substance as radiolabeled compounds
for biochemical research.
No comments or objections have been
received. The DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
American Radiolabeled Chemicals, Inc.
to manufacture the listed basic class of
controlled substance is consistent with
the public interest at this time. The DEA
has investigated American Radiolabeled
Chemicals, Inc. to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C.
823(a) and in accordance with 21 CFR
1301.33, the above named company is
granted registration as a bulk
manufacturer of the basic class of
controlled substance listed.
PO 00000
Frm 00060
Fmt 4703
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, and
dispensers of controlled substances
(other than final orders in connection
with suspension, denial, or revocation
of registration) has been re-delegated to
the Deputy Assistant Administrator of
the DEA Office of Diversion Control
(‘‘Deputy Assistant Administrator’’)
pursuant to sec. 7(g) of 28 CFR part 0,
subpart R, App.
In accordance with 21 CFR
1301.33(a), this is notice that on
February 3, 2014, Organix, Inc., 240
Salem Street, Woburn, Massachusetts
01801, made application by written
correspondence to the DEA to be
registered as a bulk manufacturer of the
following basic classes of narcotic and
nonnarcotic controlled substances:
Sfmt 4703
Dated: April 21, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2014–09552 Filed 4–25–14; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–390]
Controlled Substances: 2014
Established Aggregate Production
Quotas for Four Temporarily
Controlled Synthetic Cannabinoids
Drug Enforcement
Administration (DEA), Department of
Justice.
ACTION: Notice.
AGENCY:
This notice establishes the
initial 2014 aggregate production quotas
for four temporarily controlled synthetic
cannabinoids: N-(1-amino-3,3-dimethyl1-oxobutan-2-yl)-1-pentyl-1H-indazole3-carboxamide (ADB–PINACA); N-(1amino-3-methyl-1-oxobutan-2-yl)-1-(4fluorobenzyl)-1H-indazole-3carboxamide (AB–FUBINACA);
SUMMARY:
E:\FR\FM\28APN1.SGM
28APN1
]]>Agencies
[Federal Register Volume 79, Number 81 (Monday, April 28, 2014)]
[Notices]
[Page 23376]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-09553]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Organix,
Inc.
ACTION: Notice of application with opportunity for comment.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes and
applicants therefore may file written comments or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.33(a) on or before June 27, 2014.
ADDRESSES: Written comments should be sent via regular or express mail
to: Drug Enforcement Administration, Attention: DEA Federal Register
Representative/ODW, 8701 Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, and dispensers of controlled substances
(other than final orders in connection with suspension, denial, or
revocation of registration) has been re-delegated to the Deputy
Assistant Administrator of the DEA Office of Diversion Control
(``Deputy Assistant Administrator'') pursuant to sec. 7(g) of 28 CFR
part 0, subpart R, App.
In accordance with 21 CFR 1301.33(a), this is notice that on
February 3, 2014, Organix, Inc., 240 Salem Street, Woburn,
Massachusetts 01801, made application by written correspondence to the
DEA to be registered as a bulk manufacturer of the following basic
classes of narcotic and nonnarcotic controlled substances:
------------------------------------------------------------------------
Narcotic/
Controlled substance Schedule Nonnarcotic
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid (2010). I............... nonnarcotic
Lysergic acid diethylamide (7315) I............... nonnarcotic
Heroin (9200).................... I............... narcotic
Morphine (9300).................. II.............. narcotic
------------------------------------------------------------------------
The company plans to manufacture reference standards for
distribution to its research and forensics customers.
Dated: April 21, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014-09553 Filed 4-25-14; 8:45 am]
BILLING CODE 4410-09-P
